AUS
NZ
UK
CA
USA
IND
Here we are going to discuss three FTSE stocks, i.e. JD Wetherspoon Plc, Faron Pharmaceuticals Oy & Zinc Media Group Plc. These companies belong to Travel & Leisure, Pharmaceuticals & Biotechnology and Media Sectors, respectively. While JD Wetherspoon Plc has reported a profit in financial highlights whereas the other two company have made losses for their reported period.
JD Wetherspoon Plc
JD Wetherspoon Plc (LON:JDW) operates and owns pubs throughout Ireland and the United Kingdom. The companyâs objective is to serve the best quality drinks and food to the consumers. The companyâs pubs are uniquely created. The company has been promoting long-term relationships with its suppliers and had been using British products and support British farming.
JDW â Financial Highlights
On 20th March 2020, the company announced preliminary results for the 26 weeks ended 26th January 2020.
The operating margin increased to 8.2 per cent as compared to 7.1 per cent for 26 weeks ended 27th January 2019. The net debt to EBITDA ratio increased to 3.54 times during the 26 weeks as compared to 3.47 times and 3.36 times for 26 weeks ended 27th January 2019 and 52 weeks ended 28th July 2019.
Like-for-like sales of bar segment improved by 4.2 per cent, food segment sales increased by 5.6 per cent, and fruit/slot machines sales rose by 20.3 per cent during the 26 weeks ended 26th January 2020. However, Like-for-like hotel room sales reduced by 1.3 per cent during the 26 weeks ended 26th January 2020.
Free cash flow decreased to £49.0 million as compared to £71.7 million for 26 weeks ended 26th January 2020. It includes a capital investment of £34.5 million in existing pubs and £9.3 million for share purchases for employees. The free cash flow per share decreased by 31.2 per cent to 46.7 pence for 26 weeks ended 26th January 2020.
Assets held for sale decreased to £0.4 million versus £3.4 million as at 27th January 2019.
JDW â Share Price Performance
(Source: Thomson Reuters)
On 20th March 2020, at around 01:52 PM (GMT), by the time of writing this report, the stock of JD Wetherspoon Plc was trading at a price of GBX 734.26 per share on the London Stock Exchange, an increase in the value of around 31.24 per cent or GBX 174.76 per share, as opposed to the closing price of the stock on the previous trading day, which has been reported to be at GBX 559.50 per share.
The beta of the companyâs stock has been reported at a value of 1.7, which shows that movement of the share price is slightly more volatile against the movement in the comparative benchmark index.
At the time of writing, the companyâs market capitalisation was reported at GBP 585.68 million as regard to the stockâs current market price. The free float and outstanding shares of JD Wetherspoon Plc stood at 66.92 million and 104.68 million, respectively.
Faron Pharmaceuticals Oy
Faron Pharmaceuticals Oy (LON:FARN) is a scientific and clinical development biopharmaceutical company based out in Finland. It concentrates on organ trauma, vascular damage and immuno-oncology. The companyâs objective is to create exceptional scientific innovations for difficult to cure and rare disorders. The company is listed on the London Stock Exchange under AIM Index.
FARN â Financial Highlights
On 20th March 2020, the company announced its financial statements for the year ended 31st December 2019 and H2 2019.
During the year 2019, the company generated âZeroâ revenue. Research and development expenses decreased to â¬10.2 million versus â¬16.5 million during the year 2018. Operating loss decreased to â¬13.1 million as compared to â¬20.0 million during the year 2018.
The loss for the period decreased to â¬13.3 million as compared to â¬20.1 million during the year 2018. Basic and diluted loss per share decreased to â¬0.31 as compared to â¬0.65 during the year 2018.
The cash and cash equivalents increased to â¬7.1 million as compared to â¬4.1 million as at 31st December 2018. Non â current Borrowings increased to â¬2.3 million as compared to â¬1.9 million as at 31st December 2018.
FARN â Share Price Performance
(Source: Thomson Reuters)
On 20th March 2020, at around 01:57 PM (GMT), by the time of writing this report, the stock of Faron Pharmaceuticals Oy was trading at a price of GBX 380.50 per share on the London Stock Exchange, an increase in the value of around 0.13 per cent or GBX 0.50 per share, as opposed to the closing price of the stock on the previous trading day, which has been reported to be at GBX 380.0 per share.
The beta of the companyâs stock has been reported at a value of -0.87, which shows that movement of the share price is inversely correlated with the movement in the comparative benchmark index.
At the time of writing, the companyâs market capitalisation was reported at GBP 164.50 million regarding the stockâs current market price. The free float and outstanding shares of Faron Pharmaceuticals Oy stood at 25.46 million and 43.29 million, respectively.
Zinc Media Group Plc
Zinc Media Group Plc (LON:ZIN) is an award-winning, critically admired television and content development group. It delivers famous, pioneering and impactful programmes for the UK and international channels. The companyâs B2B segment is famous for creating cross-platform content providing awareness and brand impact in associations with clients.
ZIN â Financial Highlights
On 18th March 2020, the company declared unaudited results for the six months ended 31st December 2019.
As per the companyâs information, London & Manchester TV margins are improving far beyond the expectations, and the effect will be seen in future periods. The revenue increased by 44 per cent to £14.15 million for the six months ended 31st December 2019.
The company has raised £3.5 million of fund post period end. Gross margin ratio reduced from 28.0 per cent for the year ended June 2019 to 25.7 per cent for the half-year ended December 2019.
The loss for the period increased to £1.0 million as compared to £0.7 million for the half-year ended December 2018. Basic and diluted loss per share from continuing operations rose to 0.07 pence versus 0.05 pence for the half-year ended December 2018.
Cash and cash equivalents increased to £2.4 million as compared to £2.1 million as at 31st December 2018. The Non-current Borrowings increased to £3.8 million as compared to £3.6 million as at 31st December 2018.
ZIN â Share Price Performance
(Source: Thomson Reuters)
On 20th March 2020, at around 02:02 PM (GMT), by the time of writing this report, the stock of Zinc Media Group Plc was trading at a price of GBX 60.0 per share on the London Stock Exchange, a decrease in the value of around 1.64 per cent or GBX 1.00 per share, as opposed to the closing price of the stock on the previous trading day, which has been reported to be at GBX 61.0 per share.
The beta of the companyâs stock has been reported at a value of 1.10, which shows that movement of the share price is slightly more volatile against the movement in the comparative benchmark index.
At the time of writing, the companyâs market capitalisation was reported at GBP 4.82 million as regard to the stockâs current market price. The free float and outstanding shares of Zinc Media Group Plc stood at 6.95 million and 7.91 million, respectively.